(3S)-4-[(2S)-2-[[(2S)-1-[[(10S,23S)-23-acetamido-10-ethyl-18-fluoro-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-10-yl]oxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-[3-[2-[2-[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]-4-oxobutanoic acid
C59H73FN8O17 — CID 171621753
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-4-[(2S)-2-[[(2S)-1-[[(10S,23S)-23-acetamido-10-ethyl-18-fluoro-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-10-yl]oxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-[3-[2-[2-[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]-4-oxobutanoic acid
(3S)-4-[(2S)-2-[[(2S)-1-[[(10S,23S)-23-acetamido-10-ethyl-18-fluoro-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-10-yl]oxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-[3-[2-[2-[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]-4-oxobutanoic acid (PubChem CID 171621753) has the molecular formula C59H73FN8O17 and a molecular weight of 1185.27 g/mol. Its IUPAC name is (3S)-4-[(2S)-2-[[(2S)-1-[[(10S,23S)-23-acetamido-10-ethyl-18-fluoro-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-10-yl]oxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-[3-[2-[2-[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]-4-oxobutanoic acid.
Molecular Properties
| Compound Name | (3S)-4-[(2S)-2-[[(2S)-1-[[(10S,23S)-23-acetamido-10-ethyl-18-fluoro-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-10-yl]oxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-[3-[2-[2-[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]-4-oxobutanoic acid |
|---|---|
| PubChem CID | 171621753 |
| Molecular Formula | C59H73FN8O17 |
| Molecular Weight | 1185.27 g/mol |
| Exact Mass | 1184.51 |
| IUPAC Name | (3S)-4-[(2S)-2-[[(2S)-1-[[(10S,23S)-23-acetamido-10-ethyl-18-fluoro-19-methyl-5,9-dioxo-8-oxa-4,15-diazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16,18,20(24)-heptaen-10-yl]oxy]-3-methyl-1-oxobutan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-[3-[2-[2-[2-[6-(2,5-dioxopyrrol-1-yl)hexanoylamino]ethoxy]ethoxy]ethoxy]propanoylamino]-4-oxobutanoic acid |
| SMILES | CC[C@@]1(OC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](CC(=O)O)NC(=O)CCOCCOCCOCCNC(=O)CCCCCN2C(=O)C=CC2=O)C(C)C)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1cc(F)c(C)c3c1c2[C@@H](NC(C)=O)CC3 |
| InChI | InChI=1S/C59H73FN8O17/c1-6-59(38-27-44-53-36(30-68(44)55(77)37(38)31-84-58(59)80)51-40(62-34(5)69)14-13-35-33(4)39(60)28-41(64-53)50(35)51)85-57(79)52(32(2)3)65-54(76)43-11-10-20-66(43)56(78)42(29-49(74)75)63-46(71)17-21-81-23-25-83-26-24-82-22-18-61-45(70)12-8-7-9-19-67-47(72)15-16-48(67)73/h15-16,27-28,32,40,42-43,52H,6-14,17-26,29-31H2,1-5H3,(H,61,70)(H,62,69)(H,63,71)(H,65,76)(H,74,75)/t40-,42-,43-,52-,59-/m0/s1 |
| InChIKey | CVNMDSYWWMYYQA-NXMBFPMKSA-N |
| XLogP | 2.33 |
| TPSA | 326.57 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 85 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1185.27 |
| LogP ≤ 5 | 2.33 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 18 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171621753 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.